filmov
tv
Biotech slams study that gave Covishield an advantage, says Covaxin Ph 3 data will be out in July
Показать описание
Days after an early study claimed that the Covishield vaccine produces more antibodies against coronavirus infection than Covaxin, the latter's manufacturer on Wednesday came out with a statement and said that the preliminary research has "a lot of flaws".
► For business news on the go, download ET app:
Follow ET on:
► For business news on the go, download ET app:
Follow ET on:
Biotech slams study that gave Covishield an advantage, says Covaxin Ph 3 data will be out in July
Pakistan education system what a beautiful environment WOW🤣🤣
Coronavirus Vaccine| Bharat Biotech's Top Brass Slams Covaxin Critics| Covid-19 News | Covid Va...
The Whole Story: The Concern Around Covaxin - 12th June, 2021
Covaxin effective against Alpha & Delta Variants of Coronavirus, suggests US Studies
Top 10 College Majors That Are Actually Worth It
Science Slam 2019: Susanne Wegmann
PHT 2020 - Tech Slam from Enamine - Andrey Tarnovski
Miltenyi Science Slam 2024 - Der probiotische Trinkjoghurt
Your Tattoo is INSIDE Your Immune System. Literally
Pursuing a Career in Scientific Research | Allen Chan | TEDxYouth@DBSHK
Does Covaxin have newborn calf serum? Govt clarifies as RTI document goes viral
How to use SLAMseq for profiling transcriptional responses to drugs
WHO's Pre-Qualification Meet On Bharat Biotech's Covaxin Data Tomorrow | Breaking News
Dr. Zoë Harcombe on the Mess: The Money vs. the Evidence
Science Slam 2017: Sudha Kumari
Science Slam 2019: Jasmin Imran Alsous
CRISPR Co-Inventor Slams Claims of Gene-Edited Babies
A Journey into Epigenetics: Jewellery charms on DNA (Harshita Kaul – Science Slam)
Bharat Biotech Covaxin phase III trial is approved by Subject Expert Committee with 77.8% efficacy
Covaxin Shows 77% Efficacy In Phase 3 Trials, Bharat Biotech Informs Govt Panel, Data Under Review
Covid update: 200+ tests for every Covaxin batch; 3 times less risk after 2 doses: Study
Delta Cases On the Rise - How Are Vaccines Doing?
Bharat Biotech expects WHO nod for Covaxin between July-September
Комментарии